Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Piche Resources

July 30, 2025

Mario Innecco: Gold, Silver Breakout — What Record...

January 15, 2026

Providence Gold Mines Inc. Announces Financing Update on...

September 13, 2025

Coelacanth Energy

June 21, 2025

Blue Lagoon Resources Added to CSE25 Index –...

June 27, 2025

Top 10 Gold-mining Companies

November 13, 2025

Strategic Acquisition of Aurumin Consolidates Sandstone

July 21, 2025

Ted Butler: Silver’s Moment is Here, Time for...

July 15, 2025

Prismo Metals Announces Results of Shareholder Meeting and...

October 3, 2025

LaFleur Minerals Inc.Ideally Positioned for Significant Explorer-to-Producer Transition

December 12, 2025